Publications | Lund University Publications

11 – 17 of 17

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22SWIBREG+Study+Group%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2022
Mark Tumour necrosis factor inhibitors in Crohn's disease and the effect on surgery rates
Eberhardson, Michael ; Myrelid, Pär ; Söderling, Jonas K. ; Ekbom, Anders ; Everhov, Åsa H. ; Hedin, Charlotte R.H. ; Neovius, Martin ; Ludvigsson, Jonas F. and Olén, Ola (2022) In Colorectal Disease 24(4). p.470-483
- Contribution to journal › Article
Mark Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes : A nationwide study
Mårild, Karl ; Söderling, Jonas ; Stephansson, Olof ; Axelrad, Jordan ; Halfvarson, Jonas ; Bröms, Gabriella ; Marsal, Jan ^LU ; Olén, Ola and Ludvigsson, Jonas F. (2022) In EClinicalMedicine 53.
- Contribution to journal › Article
2021
Mark Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register–a validation study
Bröms, Gabriella ; Söderling, Jonas ; Sachs, Michael C. ; Halfvarson, Jonas ; Myrelid, Par ; Ludvigsson, Jonas F. ; Everhov, Åsa H. and Olén, Ola (2021) In Scandinavian Journal of Gastroenterology 56(4). p.410-421
- Contribution to journal › Article
Mark Predictors of drug survival : A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register
Visuri, Isabella ; Eriksson, Carl ; Olén, Ola ; Cao, Yang ; Mårdberg, Emelie ; Grip, Olof ^LU ; Gustavsson, Anders ; Hjortswang, Henrik ; Karling, Pontus and Montgomery, Scott , et al. (2021) In Alimentary Pharmacology and Therapeutics 54(7). p.931-943
- Contribution to journal › Article
Mark Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease : results from nationwide Swedish registers
Rundquist, Sara ; Sachs, Michael C. ; Eriksson, Carl ; Olén, Ola ; Montgomery, Scott and Halfvarson, Jonas (2021) In Alimentary Pharmacology and Therapeutics 53(4). p.471-483
- Contribution to journal › Article
2020
Mark The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register
Shrestha, Sarita ; Olén, Ola ; Eriksson, Carl ; Everhov, Åsa H ; Myrelid, Pär ; Visuri, Isabella ; Ludvigsson, Jonas F ; Schoultz, Ida ; Montgomery, Scott and Sachs, Michael C , et al. (2020) In Scandinavian Journal of Gastroenterology 55(4). p.430-435
- Contribution to journal › Article
Mark Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis : results from a nationwide study in Sweden
Khalili, Hamed ; Everhov, Åsa H. ; Halfvarson, Jonas ; Ludvigsson, Jonas F. ; Askling, Johan ; Myrelid, Pär ; Söderling, Jonas ; Olen, Ola ; Neovius, Martin and Olsson, Malin , et al. (2020) In Alimentary Pharmacology and Therapeutics 52(4). p.655-668
- Contribution to journal › Article

« previous
1
2
next »

your query:: Remove author: SWIBREG Study Group